Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook
Healthcare ETFs weakened Wednesday after Abbot Laboratories (NYSE: ABT) slipped on a revenue miss and revealed an uninspiring forecast for…
XBI
SPDR S&P Biotech ETF
$79.78 $-1.08
(-1.34%)
As of 7:30:00 PM EDT | 1/23/19 | Market Closed
XBI Trading Data
Open
$81.34
Low Price
$78.6
High Price
$81.77
Previous Last Price
$80.86
Bid Size
$79.71 X 1600
Ask Size
$79.85 X 1700
XBI Portfolio Data
AUM
$3,954,670,400
Shares
48,950
PE Ratio
17.32
Price / Book Ratio
4.4
Expense Ratio
0.35
Net Asset Value
$80.79
Volume
Volume
6,002,091
Avg. Volume (YDT)
5,793,380
Dollar Volume
$437,392,820
Weekly Avg. Volume
4,961,080
Monthly Avg. Volume
6,262,025
Quarterly Avg. Volume
6,958,751
XBI Fund Description
The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.
XBI Chart
XBI Summary
Fund Family
State Street Global Advisors
Tracks This Index
SPDR S&P Biotech ETF
Inception Date
2006-01-31
Asset Class
Equity
Asset Class Size
Biotech
XBI Classification
Region (General)
North America
Region (Specific)
US
Sector
Health Care
Equity Index
Leveraged Family
XBI Holdings
Top 10 Holdings
Loxo Oncology Inc (LOXO)
2.07%
Mirati Therapeutics Inc. (MRTX)
1.77%
SAGE Therapeutics Inc. (SAGE)
1.68%
Portola Pharmaceuticals Inc. (PTLA)
1.66%
Neurocrine Biosciences Inc. (NBIX)
1.58%
Celgene Corporation (CELG)
1.56%
bluebird bio Inc. (BLUE)
1.55%
Seattle Genetics Inc. (SGEN)
1.5%
FibroGen Inc. (FGEN)
1.48%
ACADIA Pharmaceuticals Inc. (ACAD)
1.46%
Total XBI Holdings
Total Holdings: 123
Loxo Oncology Inc (LOXO)
2.07%
Mirati Therapeutics Inc. (MRTX)
1.77%
SAGE Therapeutics Inc. (SAGE)
1.68%
Portola Pharmaceuticals Inc. (PTLA)
1.66%
Neurocrine Biosciences Inc. (NBIX)
1.58%
Celgene Corporation (CELG)
1.56%
bluebird bio Inc. (BLUE)
1.55%
Seattle Genetics Inc. (SGEN)
1.5%
FibroGen Inc. (FGEN)
1.48%
ACADIA Pharmaceuticals Inc. (ACAD)
1.46%
Incyte Corporation (INCY)
1.46%
Amicus Therapeutics Inc. (FOLD)
1.43%
Ultragenyx Pharmaceutical Inc. (RARE)
1.43%
Global Blood Therapeutics Inc (GBT)
1.42%
Clovis Oncology Inc. (CLVS)
1.42%
Exact Sciences Corporation (EXAS)
1.42%
Vertex Pharmaceuticals Incorporated (VRTX)
1.41%
Puma Biotechnology Inc. (PBYI)
1.37%
Regeneron Pharmaceuticals Inc. (REGN)
1.35%
Array BioPharma Inc. (ARRY)
1.35%
Ionis Pharmaceuticals Inc. (IONS)
1.35%
Madrigal Pharmaceuticals Inc. (MDGL)
1.34%
Heron Therapeutics Inc (HRTX)
1.33%
Agios Pharmaceuticals Inc. (AGIO)
1.33%
Exelixis Inc. (EXEL)
1.32%
United Therapeutics Corporation (UTHR)
1.32%
Biogen Inc. (BIIB)
1.32%
Alnylam Pharmaceuticals Inc (ALNY)
1.32%
Alexion Pharmaceuticals Inc. (ALXN)
1.32%
Amgen Inc. (AMGN)
1.31%
Gilead Sciences Inc. (GILD)
1.3%
Intercept Pharmaceuticals Inc. (ICPT)
1.29%
Spark Therapeutics Inc. (ONCE)
1.29%
BioMarin Pharmaceutical Inc. (BMRN)
1.29%
AbbVie Inc. (ABBV)
1.29%
AnaptysBio Inc. (ANAB)
1.28%
Alkermes Plc (ALKS)
1.28%
REGENXBIO Inc. (RGNX)
1.27%
Sarepta Therapeutics Inc. (SRPT)
1.26%
PTC Therapeutics Inc. (PTCT)
1.26%
TESARO Inc. (TSRO)
1.25%
Viking Therapeutics Inc. (VKTX)
1.19%
Myriad Genetics Inc. (MYGN)
1.17%
Blueprint Medicines Corp. (BPMC)
1.17%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.13%
Esperion Therapeutics Inc. (ESPR)
1.1%
Sangamo Therapeutics Inc. (SGMO)
1.1%
Repligen Corporation (RGEN)
1.08%
Arena Pharmaceuticals Inc. (ARNA)
1.07%
Ligand Pharmaceuticals Incorporated (LGND)
1.06%
Insmed Incorporated (INSM)
1.05%
Emergent BioSolutions Inc. (EBS)
1.04%
Genomic Health Inc. (GHDX)
1.01%
Enanta Pharmaceuticals Inc. (ENTA)
0.95%
Immunomedics Inc. (IMMU)
0.87%
OPKO Health Inc. (OPK)
0.84%
Spectrum Pharmaceuticals Inc. (SPPI)
0.84%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.82%
Atara Biotherapeutics Inc (ATRA)
0.8%
Editas Medicine Inc. (EDIT)
0.8%
Invitae Corp. (NVTA)
0.79%
Vanda Pharmaceuticals Inc. (VNDA)
0.75%
CareDx Inc. (CDNA)
0.71%
Acceleron Pharma Inc (XLRN)
0.7%
Intrexon Corporation (XON)
0.7%
Halozyme Therapeutics Inc. (HALO)
0.66%
ImmunoGen Inc. (IMGN)
0.65%
Radius Health Inc (RDUS)
0.62%
Aimmune Therapeutics Inc (AIMT)
0.62%
Verastem Inc. (VSTM)
0.61%
Acorda Therapeutics Inc. (ACOR)
0.6%
AMAG Pharmaceuticals Inc. (AMAG)
0.59%
Intellia Therapeutics Inc. (NTLA)
0.58%
Eagle Pharmaceuticals Inc. (EGRX)
0.58%
Iovance Biotherapeutics Inc (IOVA)
0.57%
Audentes Therapeutics Inc. (BOLD)
0.57%
Cara Therapeutics Inc (CARA)
0.55%
Natera Inc. (NTRA)
0.55%
Alder Biopharmaceuticals Inc. (ALDR)
0.54%
Flexion Therapeutics Inc. (FLXN)
0.53%
Vericel Corporation (VCEL)
0.53%
Dynavax Technologies Corporation (DVAX)
0.51%
Coherus BioSciences Inc. (CHRS)
0.48%
Momenta Pharmaceuticals Inc. (MNTA)
0.44%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
0.44%
Xencor Inc. (XNCR)
0.4%
G1 Therapeutics Inc. (GTHX)
0.38%
Fate Therapeutics Inc. (FATE)
0.37%
Karyopharm Therapeutics Inc. (KPTI)
0.36%
Epizyme Inc. (EPZM)
0.35%
Novavax Inc. (NVAX)
0.35%
Progenics Pharmaceuticals Inc. (PGNX)
0.35%
TG Therapeutics Inc. (TGTX)
0.34%
Retrophin Inc. (RTRX)
0.34%
Solid Biosciences Inc. (SLDB)
0.31%
Denali Therapeutics Inc. (DNLI)
0.3%
Dicerna Pharmaceuticals Inc. (DRNA)
0.29%
CytomX Therapeutics Inc. (CTMX)
0.28%
Deciphera Pharmaceuticals Inc. (DCPH)
0.28%
ArQule Inc. (ARQL)
0.24%
Sorrento Therapeutics Inc. (SRNE)
0.23%
Rigel Pharmaceuticals Inc. (RIGL)
0.23%
Prothena Corp. Plc (PRTA)
0.22%
Inovio Pharmaceuticals Inc. (INO)
0.22%
Allakos Inc. (ALLK)
0.2%
BioCryst Pharmaceuticals Inc. (BCRX)
0.19%
MacroGenics Inc. (MGNX)
0.18%
PDL BioPharma Inc. (PDLI)
0.17%
Five Prime Therapeutics Inc. (FPRX)
0.17%
GlycoMimetics Inc. (GLYC)
0.17%
Rhythm Pharmaceuticals Inc. (RYTM)
0.16%
Athenex Inc. (ATNX)
0.16%
Akebia Therapeutics Inc. (AKBA)
0.15%
Kura Oncology Inc. (KURA)
0.15%
Apellis Pharmaceuticals Inc. (APLS)
0.14%
ZIOPHARM Oncology Inc. (ZIOP)
0.14%
Stemline Therapeutics Inc. (STML)
0.13%
Achillion Pharmaceuticals Inc. (ACHN)
0.13%
Lexicon Pharmaceuticals Inc. (LXRX)
0.12%
STATE STREET INSTL US GOVERNME STIF USD (Unassigned)
0.12%
Cytokinetics Incorporated (CYTK)
0.09%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%
XBI Technicals
Alpha
-8
Beta
1.65
Leverage
Long
Standard Deviation
8.58
XBI Dividends
Dividend Date
2018-12-21
Latest Dividend
0.012
Annual Dividend
0.2
Annual Dividend Rate
0.2
Annual Dividend Yield
0.25
XBI Performance
YTD Return
11.19%
1 Year Return
-16.74%
3 Year Return
59.96%
5 Year Return
61.49%
10 Year Return
359.69%
XBI Related Articles
Biotech ETFs Surge After Eli Lilly Buys Out Loxo Oncology
Biotechnology stocks and sector-related ETFs were among the best performers Monday after Eli Lilly (NYSE: LLY) said it will acquire…
Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat
Stocks rallied Wednesday, a day after one of the most contentious midterm elections in U.S. history. In Tuesday’s midterm elections,…
Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend
Biotechnology sector-related exchange traded funds were among the few areas of the markets that shook off the tariffs-talk volatility and…
6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has…
Catalysts Abound for Biotech ETFs
Biotechnology stocks and biotech ETFs tumbled in the back half of March and to start April. For example, the SPDR…